TipRanks
Go Ultimate55% OFF

Gary Evans Insider Profile

18 Followers

Gary Evans, Chairman & CEO, Director at United States Antimony, holds 2.59M shares in United States Antimony (Ticker: UAMY), holds 19.55K shares in Novavax (Ticker: NVAX), holds 3.78M shares in Magnum Hunter (Ticker: MHRCQ). Most recently, Gary Evans Bought ― shares of United States Antimony on Aug 28, 2026 for an estimated value of $98.40K.

Gary Evans's Trading History

UAMY
United States Antimony
Aug 28, 2026Chairman & CEO, DirectorInformative Buy98.40K$7.72M
NVAX
Novavax
Jun 22, 2021DirectorUninformative Buy620.62K$197.05K
MHRCQ
Magnum Hunter
Jan 12, 2016―Uninformative Sell―$37.81K
GRHHQ
Greenhunter Energy Inc
Jan 27, 2015―Informative Buy100.00K$70.82K

You May Also Like

Gary Evans insider profile FAQ

What is the percentage of profitable transactions made by Gary Evans?
The percentage of profitable transactions made by Gary Evans is 26%.
What is the average return per transaction made by Gary Evans?
The average return per transaction made by Gary Evans is -2.40%.
What stocks does Gary Evans hold?
Gary Evans holds: UAMY, GRHHQ, MHRCQ, NVAX stocks.
What was Gary Evans’s latest transaction?
Gary Evans’s latest transaction was an Informative Buy of $98.40K.
What was Gary Evans's most profitable transaction?
Gary Evans’s most profitable transaction was an Informative Buy of UAMY stock on December 11, 2024. The return on the trade was 300.00%.
What is Gary Evans's role in United States Antimony?
Gary Evans's role in United States Antimony is Chairman & CEO, Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.

TipRanks measures corporate insiders by the stock transactions they report to the SEC. See how TipRanks ranks experts and calculates performance.